Commensal microbiota from patients with inflammatory bowel disease produce genotoxic metabolites

Science. 2022 Oct 28;378(6618):eabm3233. doi: 10.1126/science.abm3233. Epub 2022 Oct 28.

Abstract

Microbiota-derived metabolites that elicit DNA damage can contribute to colorectal cancer (CRC). However, the full spectrum of genotoxic chemicals produced by indigenous gut microbes remains to be defined. We established a pipeline to systematically evaluate the genotoxicity of an extensive collection of gut commensals from inflammatory bowel disease patients. We identified isolates from divergent phylogenies whose metabolites caused DNA damage and discovered a distinctive family of genotoxins-termed the indolimines-produced by the CRC-associated species Morganella morganii. A non-indolimine-producing M. morganii mutant lacked genotoxicity and failed to exacerbate colon tumorigenesis in mice. These studies reveal the existence of a previously unexplored universe of genotoxic small molecules from the microbiome that may affect host biology in homeostasis and disease.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carcinogenesis / genetics
  • Colorectal Neoplasms* / genetics
  • Colorectal Neoplasms* / microbiology
  • DNA Damage*
  • Gastrointestinal Microbiome*
  • HeLa Cells
  • Humans
  • Indoles* / metabolism
  • Inflammatory Bowel Diseases* / microbiology
  • Mice
  • Morganella morganii* / genetics
  • Morganella morganii* / isolation & purification
  • Morganella morganii* / metabolism
  • Mutagens* / metabolism

Substances

  • Indoles
  • Mutagens